Universität zu Köln

Waldschmidt, D., El-Khoueir, A. B., Kim, R. D., Harris, W. P., Sung, M. W., Iqbal, S., Zhang, A., Nakajima, K. and Galle, P. R. (2020). Phase 1b study of regorafenib (REG) plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC). Oncol. Res. Treat., 43 (SUPPL 4). S. 123 - 124. BASEL: KARGER. ISSN 2296-5262

Full text not available from this repository.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Waldschmidt, D. UNSPECIFIED UNSPECIFIED UNSPECIFIED El-Khoueir, A. B. UNSPECIFIED UNSPECIFIED UNSPECIFIED Kim, R. D. UNSPECIFIED UNSPECIFIED UNSPECIFIED Harris, W. P. UNSPECIFIED UNSPECIFIED UNSPECIFIED Sung, M. W. UNSPECIFIED UNSPECIFIED UNSPECIFIED Iqbal, S. UNSPECIFIED UNSPECIFIED UNSPECIFIED Zhang, A. UNSPECIFIED UNSPECIFIED UNSPECIFIED Nakajima, K. UNSPECIFIED UNSPECIFIED UNSPECIFIED Galle, P. R. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-317322
Journal or Publication Title:	Oncol. Res. Treat.
Volume:	43
Number:	SUPPL 4
Page Range:	S. 123 - 124
Date:	2020
Publisher:	KARGER
Place of Publication:	BASEL
ISSN:	2296-5262
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language Oncology Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/31732